DFX Intelligence

Data Factory

RIA / WealthPrivate fundventure capital fund3(c)(1)dropped

ISRAEL BIOTECH FUND I, L.P.

Cayman Islands

This is the graph view. The full profile, with its team, deals and sources, is on RIA / Wealth Management.Open the full profile →

Search this name across graphsid dfx:ria:ac135c9a-9d65-7c0e-d5ad-bf407e336ed7

Data as of Feb 15, 2019 (this record's last observation) from federal regulator filings. Page built Sep 21, 2026, 7:28 AM UTC and rebuilt at most every 15 minutes.

Relationships: 0
Dated events: 0
On other graphs: 3
Observed: Apr 12, 2016 to Feb 15, 2019
4 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

Israel Biotech Fund I, L.P.

Private equity fund · shared adv fund id

Venture Capitalidentity

Israel Biotech Fund I, L.P.

Venture fund · shared adv fund id

RIA / Wealth Managementidentity

ISRAEL BIOTECH FUND I, L.P.

Private fund · shared adv fund id

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Fund type: Venture Capital Fund
Latest reported GAV: $25.0Mgross asset value on Schedule D 7.B(1), as of 2019-02-15; never fund size
Peak reported GAV: $25.0M
Beneficial owners: 61
Minimum investment: $25,000
Owned by the adviser: 500%
Owned by funds of funds: 0%
Owned by non-US persons: 4000%
Clients solicited: no
Form D file number: 021-249881an SEC offering identifier; the Form D vehicle on the venture or private equity graph is linked above when the identity layer has it
Organised in: Cayman Islands
First reported: Apr 12, 2016
Last reported: Feb 15, 2019fund reporting on the SEC extract ends 2024-12-31
Filings reporting it: 4
Fund id: 805-7967344161

Reported gross asset value by filing

each Schedule D 7.B(1) row as filed; GAV is gross asset value, never fund size

Filed	GAV	Owners	Minimum	Adviser owns	Audited	Name as filed
Feb 15, 2019	$25.0M	61	$25,000	500.0%	yes	ISRAEL BIOTECH FUND I, L.P.
Mar 7, 2018	$25.0M	61	$25,000	500.0%	yes	ISRAEL BIOTECH FUND I, L.P.
Mar 6, 2017	$0	45	$25,000	500.0%	yes	ISRAEL BIOTECH FUND I, L.P.
Apr 12, 2016	$0	45	$25,000	500.0%	yes	ISRAEL BIOTECH FUND I, L.P.

Relationships

No published relationship touches this entity yet.

Dated events

No dated event names this entity yet.

Provenance

Graph: RIA / Wealth Management
Canonical id: dfx:ria:ac135c9a-9d65-7c0e-d5ad-bf407e336ed7
First observed: Apr 12, 2016
Last observed: Feb 15, 2019 92 months ago
Source families: Federal regulator filings
1 registered feed stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

ISRAEL BIOTECH FUND I, L.P.

Cayman Islands

This is the graph view. The full profile, with its team, deals and sources, is on RIA / Wealth Management.Open the full profile →

Search this name across graphsid dfx:ria:ac135c9a-9d65-7c0e-d5ad-bf407e336ed7

Data as of Feb 15, 2019 (this record's last observation) from federal regulator filings. Page built Sep 21, 2026, 7:28 AM UTC and rebuilt at most every 15 minutes.

Filed

GAV

Owners

Minimum

Adviser owns

Audited

Name as filed

Feb 15, 2019

$25.0M

$25,000

500.0%

yes

ISRAEL BIOTECH FUND I, L.P.

Mar 7, 2018

$25.0M

$25,000

500.0%

yes

ISRAEL BIOTECH FUND I, L.P.

Mar 6, 2017

$25,000

500.0%

yes

ISRAEL BIOTECH FUND I, L.P.

Apr 12, 2016

$25,000

500.0%

yes

ISRAEL BIOTECH FUND I, L.P.